Not directly related to the article content. Photo by Getty Images Bank

Not directly related to the article content. Photo by Getty Images Bank

View original image


[Asia Economy Reporter Na Ye-eun] New Zealand authorities have announced test results indicating a link between the Pfizer COVID-19 vaccine and the death of a man in his 20s from myocarditis.


According to major foreign media on the 20th (local time), the New Zealand COVID-19 Vaccine Safety Monitoring Committee stated, "The cause of death of a 26-year-old man who died within two weeks of receiving the first dose of the Pfizer vaccine from myocarditis is likely due to the vaccination."


Myocarditis, an inflammation of the heart muscle, is known as a rare side effect reported after mRNA (messenger RNA) vaccines.


This is the second time New Zealand health authorities have linked vaccine-related side effects to the death of a vaccine recipient, following the death of a woman from myocarditis in August.


Meanwhile, the committee also announced that a 13-year-old adolescent and a man in his 60s died from myocarditis after vaccination on the same day.


The committee explained that the death of the man in his 60s does not appear to be related to the vaccine, but more details are needed regarding the association with the adolescent's death.



However, the committee emphasized, "Despite these rare side effects, the benefits gained from vaccination far outweigh the risks."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing